Hematological Malignancy

DBCOND0031698Hemic and Lymphatic DiseasesNeoplasms

Hematological Malignancy is the indication for 6 drugs in DrugBank. It is covered by 8 curated, structured indications.

Also known as
Haematopoietic neoplasm · Hematologic Malignancies · Hematological Malignancies · Hematologic Malignancy · Malignant Hemopathy
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0028785ICD-10C96.9SNOMED CT127221002MedDRA10018864UMLSC0348393

What you can answer from here — as of October 22, 2026

6Indicated drugsWith each drug's targets and mechanism
Listed above
8Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
666Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Boxed warningsLabel boxed warnings that name this condition
Sign in
6Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Hematological Malignancy share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In